Quarterly report · Q1
2533.TEDINET S100TDK1
Period2024-01-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.8bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥84.9bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥624m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥876m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥673m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.7bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥882m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥670m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥882m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥498m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.4bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥797m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥498m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥788m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥55.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥55.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥53.8bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.6bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥33.2bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.1bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥987m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥828m | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥8.57 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.3 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.7 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-03-31 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-03-31 | ¥19m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | ¥3m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥3m |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥1.1bn |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥1.1bn |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥172m |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥17.4bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥17.4bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥295m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥283m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥283m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥152m |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥18.8bn |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥18.8bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥1m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥620m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥921m |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥921m |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥265m |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥18.3bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥18.3bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥485m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥252m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥252m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥130m |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥6m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥20.8bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥20.8bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 400
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 田 大 輔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 宮 正 俊 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 20844000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 18827000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 84947000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 882000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 673000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 3702000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 797000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 498000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 3393000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 822000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 981000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 3910000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 20129000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 22734000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 22227000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 53797000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 55367000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 55431000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 13.70 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 8.57 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 58.30 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.340 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.395 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.386 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 65586196 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7375700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 58140100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 581401 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 70396 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 65586196 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 588660 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 6649800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | 725900 | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7375700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1124 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |